On 29 November 2017 we launched recommendations on the long-term health, well-being and chronic care of people living with HIV (PLHIV).
Upcoming events and past event reports for HIV Outcomes initiative meetings, launches and other events.
Regularly updated news, press releases, downloads and more information on the HIV Outcomes initiative.
The initiative

The HIV Outcomes initiative was created in 2016. It reflected a widespread recognition among experts that important issues of health and social inclusion of people living with HIV (PLHIV) receive insufficient attention from policy makers and healthcare providers. The initiative aims to make these elements central to the overall response to HIV.

Events All

Past Events
29 November European Parliament, Brussels

Updates All

21 December 2018
Thank you very much for your support this year! 2018 has been busy for HIV Outcomes! In an effort to achieve better long-term health outcomes and quality of life for people living with HIV, this year the HIV Outcomes initiative road-tested ...
27 November 2018
The HIV Outcomes Steering Group ‘road-tested’ the HIV Outcomes recommendations in Italy and Sweden this year to confirm that they are fit for implementation.
Press Releases
HIV Outcomes will today (27 November) launch an Online Compendium of Good Practices for securing the long-term health and well-being of people living with HIV.

@HIVOutcomes Follow us on Twitter

Steering Group member Mario Cascio @EATGx expands on one of @HIVOutcomes' key goals: "We must shift the narrative - we should no longer speak about 'long-term survival' but about 'quality of life' of people living with #HIV" #BeyondViralSuppression
19 February at 11:31am
View on
RT @WHO_Europe: You will not get HIV from shaking hands with a colleague 🤝 Stigma and discrimination in the workplace don’t support qualit…
18 February at 3:16pm
View on
We are now also on LinkedIn and YouTube! Follow us and join the discussion #LinkedIn & #YouTube
18 February at 10:54am
View on
Initiative Partners
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.